Actuate Therapeutics Inc (ACTU)
R&D Expenses
$8.94M
TTM · Period ending: · USD
ACTU R&D Expenses
Latest reported$8.94Mperiod ending
Latest reported$8.94Mperiod ending
ACTU TTM R&D Expenses ($21.71M → $8.94M)
TTM R&D Expenses
High-resolution chart · PNG
ACTU r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 8,939,565 | |
| 9,637,545 | |
| 10,292,620 | |
| 11,848,985 | |
| 13,428,165 | |
| 15,036,165 | |
| 18,676,276 | |
| 21,636,164 | |
| 23,640,568 | |
| 24,045,005 | |
| 21,708,332 |